Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Digital Health Today-Resources Digital Health Today Ambassadors

Digital Therapeutics Edition

Ep10: Leveraging Novel Technologies to Meet Unmet Medical Needs – Brent Vaughan CEO, Cognito Therapeutics

DTx Solutions for neurodegenerative diseases
March 2, 2021
Ep10: Leveraging Novel Technologies to Meet Unmet Medical Needs – Brent Vaughan CEO, Cognito Therapeutics
Advertisement
DOCSF 2021

There are two kinds of people in the world, says Brent Vaughan — those who prefer to make incremental changes with a lower likelihood of failure, and those who aspire to fix (seemingly) intractable problems that have stymied others. Brent falls in the latter category. A serial entrepreneur, former venture capitalist, and current CEO of Cognito Therapeutics (a DTx company that specializes in neurodegenerative diseases), Brent is also uniquely positioned to evaluate the future of next generation digital therapeutics.

Brent and Eugene talk about the differences between prescription and business-to-consumer DTx, the importance of engaging patients and users early on in the development of novel products, and the exciting potential of translational DTx solutions. Eugene’s podcast partner, Brian Dolan, also pops in with a question.

>>Click here to read the transcript

Guest Links and Resources:

Host Links and Resources:

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

cover
Ep17: Treating Chronic Pain with DTx How Kaia is giving people back their most valuable resource—time
X
X